Palindromic rheumatism: A pre-rheumatoid arthritis state?

Journal of Rheumatology

Volumn 39, Issue 10, 2012, Pages 1912-1913

  Katz, Steven J ^a   Russell, Anthony S ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICITRULLINATED PROTEIN ANTIBODY; BIOLOGICAL MARKER; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; DIAGNOSTIC TEST; DRUG SAFETY; EARLY INTERVENTION; EDITORIAL; HUMAN; PALINDROMIC RHEUMATISM; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REMISSION; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

EID: 84867060280     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120995     Document Type: Editorial

References (7)

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet;376:1094-108.
2. Powell A, Davis P, Jones N, Russell AS. Palindromic rheumatism is a common disease: Comparison of new-onset palindromic rheumatism compared to new-onset rheumatoid arthritis in a 2-year cohort of patients. J Rheumatol 2008;35:992-4. (Pubitemid 351813142)
3. Koskinen E, Hannonen P, Sokka T. Palindromic rheumatism: Longterm outcomes of 60 patients diagnosed in 1967-84. J Rheumatol 2009;36:1873-5.
4. Sanmartí R, Cabrera-Villalba S, Gómez-Puerta JA, Ruiz-Esquide V, Hernández MV, Salvador G, et al. Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study. J Rheumatol 2012;39:1929-33.
5. Russell AS, Devani A, Maksymowych WP. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. J Rheumatol 2006;33:1240-2. (Pubitemid 44025133)
6. Tamai M, Kawakami A, Iwamoto N, Arima K, Aoyagi K, Eguchi K. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism. Scand J Rheumatol 2010;39:287-91.
7. Gonzalez-Lopez L, Gamez-Nava JI, Jhangri G, Russell AS, Suarez-Almazor ME. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. J Rheumatol 2000;27:41-6. (Pubitemid 30058627)